대한부인종양학회

최신 논문

총 게시글 : 216

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer 2026-09-30 VIEW : 2
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249 2026-09-30 VIEW : 1
FIGO staging for gestational trophoblastic neoplasia: 2026 2026-09-30 VIEW : 4
Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia 2026-09-30 VIEW : 3
No time to waste: Evaluation of diagnostic delays in vulvar cancer 2026-09-30 VIEW : 3
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study 2026-06-24 VIEW : 10
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer 2026-06-24 VIEW : 6
Quality-adjusted progression-free survival analysis of veliparib and carboplatin/paclitaxel compared with chemotherapy alone in patients with newly diagnosed ovarian cancer (VELIA/GOG3005): ancillary analysis of a placebo-controlled, phase 3 randomized tr 2026-06-24 VIEW : 4
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial 2026-06-24 VIEW : 6
Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer 2026-06-24 VIEW : 4
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer 2026-06-24 VIEW : 2
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial 2026-06-24 VIEW : 3
Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025) 2026-06-24 VIEW : 8
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study 2026-06-24 VIEW : 5
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial 2026-06-24 VIEW : 2

1
2
3
4
5
6
7
8
9
10
...
14
15